semaglutide fda shortage status january 2025 declares end to Wegovy and Ozempic GLP-1 No Longer on FDA's – The GLP-1 drug boom has

At present, no pharmacologic agent is standard of care to preserve muscle during GLP-1RA therapy

Stopping either medication often leads to weight regain, as the appetite-suppressing effects diminish once treatment ends

Abdulghani, AA

Our comprehensive program incorporates, weight loss medicine, supplements, nutrition counseling, fitness coaching, and ongoing support to empower you to make lasting changes

You might hear them called GLP-1 analogs or incretin mimetics. While the first version was approved in 2005, modern options like Ozempic, Wegovy, and Zepbound have revolutionized the field by offering once-weekly dose to get superior results

The program offers both Food and Drug Administration (FDA)-approved and compounded bioidentical hormones, integrated with food tracking, movement support, and expert guidance